Skip to main content

Table 4 Dose Escalation Regression Estimates – Inflixim ab Dependent Variables (Increase in dose for Inflixim ab 1 = yes, 0 = no)

From: Patterns of use, dosing, and economic impact of biologic agent use in patients with rheumatoid arthritis: a retrospective cohort study

Parameter Level Estimate Odds-Ratio Conditional Probability p-value
Intercept   -0.0732 0.93 n.a. 0.8209
Age Group      
  0–34 0.0000 1.00 0.48  
  34–54 0.6639 1.94 0.64 0.0682
  45–54 0.3808 1.46 0.58 0.2594
  55+ 0.0648 1.07 0.50 0.8469
HMO HMO -0.3810 0.68 0.39 0.0372
Pre-Index Therapy Methotrexate 0.3900 1.48 0.58 0.0216